Expertise in
6
conditions

Alexandros A. Garyfallos

Konstantinoupoleos Str. 49, 
Thessaloniki, ESYE12, GR 
Expertise in
6
conditions
Konstantinoupoleos Str. 49, 
Thessaloniki, ESYE12, GR 

Overview

Alexandros Garyfallos practices practicing medicine in Thessaloniki, Greece.

Mr. Garyfallos is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Arthritis, Juvenile Idiopathic Arthritis (JIA), Systemic Sclerosis (SSc), and Scleroderma.

He is actively involved in clinical research, co-authoring 65 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

Konstantinoupoleos Str. 49, Thessaloniki, ESYE12, Greece

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 22, 2025
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 2 Less Clinical Trials

65 Total Publications

Characterization of T-bet expressing B cells in lupus patients indicates a putative prognostic and therapeutic value of these cells for the disease.
Characterization of T-bet expressing B cells in lupus patients indicates a putative prognostic and therapeutic value of these cells for the disease.
Journal: Clinical and experimental immunology
Published: September 30, 2024

Frequently Asked Questions about Alexandros A. Garyfallos

Is Alexandros A. Garyfallos a top-rated expert for Arthritis?

MediFind is an objective health platform that identifies experts based on real-world data. Alexandros A. Garyfallos is classified as an Advanced expert for Arthritis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Alexandros A. Garyfallos participate in research or clinical trials?

Yes. Alexandros A. Garyfallos has published 65 articles and abstracts on conditions like Arthritis. You can view a list of Alexandros A. Garyfallos's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Garyfallos's expertise for a condition
ConditionClose
      View All 26 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile